Correvio Pharma Corp. Deferred Tax Assets, Gross
Correvio Pharma Corp. had Deferred Tax Assets, Gross of $39.29 million as of 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2020-04-30
- 2019-12-31: Deferred Tax Assets, Gross $39.29M.
- 2018-12-31: Deferred Tax Assets, Gross $27.78M.
- 2017-12-31: Deferred Tax Assets, Gross $114.80M.
- 2016-12-31: Deferred Tax Assets, Gross $113.31M.
| Period end | Deferred Tax Assets, Gross | Deferred Tax Assets, Gross as first filed |
|---|---|---|
| 2019-12-31 | $39.29M 20-F · filed 2020-04-30 | |
| 2018-12-31 | $27.78M 20-F · filed 2020-04-30 | |
| 2017-12-31 | $114.80M 40-F · filed 2019-03-13 | |
| 2016-12-31 | $113.31M 20-F · filed 2018-04-30 | |
| 2015-12-31 | $109.13M 40-F · filed 2017-03-29 | |
| 2014-12-31 | $104.17M 40-F · filed 2016-03-29 | |
| 2013-12-31 | $102.20M 40-F · filed 2015-03-27 | $87.80M 40-F · filed 2014-03-27 |
| 2012-12-31 | $77.89M 40-F/A · filed 2014-04-30 | |
| 2011-12-31 | $73.89M 20-F/A · filed 2013-04-18 |